Why is Biogen Pharma falling/rising?

As of 09-Sep, Biogen Pharmachem Industries Ltd is currently priced at 0.89, showing no change (0.00%). The stock has underperformed in the short term, with a 1-week return of -2.20% and a 1-month return of -3.26%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Investor participation has also declined, with a delivery volume of 3.97 lacs on September 8, which is down by 0.5% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader market context shows that while Biogen Pharma has struggled, the benchmark Sensex has performed positively, gaining 1.18% over the past week and 1.56% over the past month. This stark contrast highlights the stock's underperformance relative to the broader market, where it has also lagged significantly year-to-date with a decline of 24.58% compared to the Sensex's increase of 3.79%. The overall market conditions appear to be favorable, yet Biogen Pharma's stock continues to face challenges, contributing to its recent price stagnation.